English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy Journal article
Xiang, Feifan, Liu, Huipan, Deng, Jia, Ma, Wenzhe, Chen, Yue. Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy[J]. Cancers, 2022, 14(23).
Authors:  Xiang, Feifan;  Liu, Huipan;  Deng, Jia;  Ma, Wenzhe;  Chen, Yue
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:4.5/4.9 | Submit date：2023/01/30
Denosumab  Dose  Duration Of Therapy  Giant Cell Tumor Of Bone  
IPO underpricing and mutual fund allocation: New evidence from registration system Journal article
Sun, Feifan, Yin, Chen, Zhou, Sili, Zhu, Zijing. IPO underpricing and mutual fund allocation: New evidence from registration system[J]. International Review of Financial Analysis, 2022, 84, 102405.
Authors:  Sun, Feifan;  Yin, Chen;  Zhou, Sili;  Zhu, Zijing
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:7.5/7.7 | Submit date：2022/12/01
Investor Behavior  Ipo  Mutual Fund Allocation  Underpricing  
Hydrophobic hydrogels as internal curing agent for concrete: The double benefit of super high water content and excellent anti-ion permeability Journal article
Cui, Hongyuan, Chen, Feifan, Liao, Yang, Liang, Zexuan, Luo, Lu, Wang, Xiaolin, Guo, Honglei, Zhao, Jihui, Meng, Guozhe, Ouyang, Gangfeng, Ke, Wei, Guo, Hui. Hydrophobic hydrogels as internal curing agent for concrete: The double benefit of super high water content and excellent anti-ion permeability[J]. Composites Communications, 2022, 33.
Authors:  Cui, Hongyuan;  Chen, Feifan;  Liao, Yang;  Liang, Zexuan;  Luo, Lu; et al.
Favorite | TC[WOS]:10 TC[Scopus]:11  IF:6.5/6.6 | Submit date：2023/01/30
Concrete  Hydrogels  Internal Curing Agent  Ion-permeability